AstraZeneca Will Test More Assets Against COVID-19

Uses Q1 Update To Outline Coronavirus Efforts

AstraZeneca, during a strong first-quarter update, underscored its determination to test existing portfolio assets for use in fighting the COVID-19 pandemic.

Covid-19
Group hopes portfolio drugs can ease COVID-19 organ damage • Source: Shutterstock

More from Clinical Trials

More from R&D